11 results match your criteria: "National Center of Competence in Research (NCCR)Molecular Oncology[Affiliation]"

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Nat Med

November 2014

1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France.

Article Synopsis
  • - Anthracyclines trigger immune responses against cancer by activating the TLR3 receptor in malignant cells, leading to the production of type I interferons (IFNs).
  • - These IFNs bind to receptors on cancer cells, causing them to release the chemokine CXCL10, which is vital for the tumor response to chemotherapy.
  • - A specific type I IFN signature in patients may indicate how well they will respond to anthracycline chemotherapy, suggesting that these treatments can mimic the body's reaction to viral infections.
View Article and Find Full Text PDF

The niche under siege: novel targets for metastasis therapy.

J Intern Med

August 2013

École Polytechnique Fédérale de Lausanne (EPFL), ISREC (Swiss Institute for Experimental Cancer Research), National Center of Competence in Research (NCCR) 'Molecular Oncology', Lausanne, Switzerland.

Metastasis is an inefficient process and most cancer cells fail to colonize secondary sites. There are several possible reasons for this. First, the nature of the infiltrating cells is important as a small population of cancer stem cells has been shown to have exclusive metastasis-initiating potential.

View Article and Find Full Text PDF

Cancer stem cells: never Wnt away from the niche.

Curr Opin Oncol

January 2009

Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC (Swiss Institute for Experimental Cancer Research), National Center of Competence in Research (NCCR) Molecular Oncology, Epalinges, Switzerland.

Purpose Of Review: The last years of cancer research have established the concept of cancer stem cells (CSCs) as a subpopulation of cells within a tumor entirely responsible for tumorigenesis. This has aroused expectations that targeting cancer stem cells would allow effective tumor eradication. This review aims to summarize the relevant achievements in the field and to highlight the complex mechanisms that are involved in regulating CSC function.

View Article and Find Full Text PDF

Adeno-associated virus (AAV) DNA, by mimicking a stalled replication fork, provokes a DNA damage response that can arrest cells in the G2/M phase of the cell-cycle. This response depends strictly on DNA damage signaling kinases ATR and Chk1. Here, we used AAV to study long-term effects of DNA damage signaling in cells with altered p53 status.

View Article and Find Full Text PDF

The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes.

Pigment Cell Res

June 2007

Swiss Institute for Experimental Cancer Research (ISREC), National Center of Competence in Research (NCCR) Molecular Oncology, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.

The terminal differentiation of melanocytes is associated with the transcriptional activation of genes responsible for pigment production such as tyrosinase. Pigment cell-specific transcription factors, such as Mitf, as well as specific proximal and distal regulatory elements (DRE) are implicated in the tight control of tyrosinase expression during development and adulthood. Proper tyrosinase expression in melanocytes depends upon the presence of a DRE that is located at -15 kb and provides enhancer activity via a central element termed core-enhancer.

View Article and Find Full Text PDF

Alveolar and lactogenic differentiation.

J Mammary Gland Biol Neoplasia

October 2006

National Center of Competence in Research (NCCR) Molecular Oncology, Swiss Institute for Experimental Cancer Research (ISREC), 155 Chemin des Boveresses, CH-1066, Epalinges, Lausanne, Switzerland.

The mouse mammary gland is a complex tissue that proliferates and differentiates under the control of systemic hormones during puberty, pregnancy and lactation. Once a highly branched milk duct system has been established, during mid/late pregnancy, alveoli, little saccular outpouchings, sprout all over the ductal system and differentiate to become the sites of milk secretion. Here, we review the emerging network of the signaling pathways that connects hormonal stimuli with locally produced signaling molecules and the components of intracellular pathways that regulate alveologenesis and lactation.

View Article and Find Full Text PDF

A conserved transcriptional enhancer that specifies Tyrp1 expression to melanocytes.

Dev Biol

October 2006

ISREC (Swiss Institute for Experimental Cancer Research), National Center of Competence in Research (NCCR) Molecular Oncology, Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.

Pigment cells of mammals originate from two different lineages: melanocytes arise from the neural crest, whereas cells of the retinal pigment epithelium (RPE) originate from the optic cup of the developing forebrain. Previous studies have suggested that pigmentation genes are controlled by different regulatory networks in melanocytes and RPE. The promoter of the tyrosinase-related family gene Tyrp1 has been shown to drive detectable transgene expression only to the RPE, even though the gene is also expressed in melanocytes as evident from Tyrp1-mutant mice.

View Article and Find Full Text PDF

The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model.

Pigment Cell Res

August 2005

Swiss Institute for Experimental Cancer Research (ISREC), National Center of Competence in Research (NCCR) Molecular Oncology, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.

Fibroblast growth factor 2 (FGF2) has been assigned a role in melanocyte proliferation and in development of human cutaneous melanoma. We have used a transgenic mouse melanoma model in combination with mice lacking mouse FGF2 to analyse the possible implication of FGF2 in melanomagenesis. Tyr::N-rasQ61K transgenic mice which are deficient for FGF2 and the tumor suppressors p16INK4a and p19ARF are hyperpigmented and develop cutaneous metastasizing melanoma, with no difference to mice wildtype for FGF2.

View Article and Find Full Text PDF

Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation.

J Biol Chem

January 2005

Centre Pluridisciplinaire d'Oncologie (CePO) and Swiss Institute for Experimental Cancer Research (ISREC), National Center of Competence in Research (NCCR) Molecular Oncology, CH-1066 Epalinges s/Lausanne, Switzerland.

Cyclooxygenase-2 (COX-2), a key enzyme in prostaglandin synthesis, is highly expressed during inflammation and cellular transformation and promotes tumor progression and angiogenesis. We have previously demonstrated that endothelial cell COX-2 is required for integrin alphaVbeta3-dependent activation of Rac-1 and Cdc-42 and for endothelial cell spreading, migration, and angiogenesis (Dormond, O., Foletti, A.

View Article and Find Full Text PDF

The albino mouse was already known in ancient times and was apparently selectively bred in Egypt, China, and Japan. Thus, it is not surprising that the c or albino locus (now the Tyr locus) was among the first used to demonstrate Mendelian inheritance in mammals at the dawn of the past century. This locus is now known to encode tyrosinase, the rate-limiting enzyme in the production of melanin pigment, and the molecular basis of the albino ( Tyr(c)) mutation is known.

View Article and Find Full Text PDF

The human papillomavirus (HPV) is the most significant causative agent in the development of cervical cancer. Despite its presence in almost all cervical cancers, HPV by itself is unable to transform a normal cell to a cancerous one. Instead, additional cellular mutations are required to supplement the HPV oncoproteins E6 and E7.

View Article and Find Full Text PDF